The biological half-life of synthetic, radiochemically pure, biologically active [ 3H] 8\ x=req-\ arginine-vasopressin ([3H]AVP), the distribution of radioactivity among the organs and the in-vivo metabolism of the hormone were studied in the rat. The half-life calculated from the [3H]AVP radioactivities isolated from the blood was found to be 1\m=.\74\ m=+-\ 0\m=.\22 (s.d.) min in the fast phase, and 16\m=.\98\ m=+-\ 1\ m=. \ 01 min in the slow phase. The half-lives of total radioactivity were longer in both phases. The radioactivity accumulated to the greatest extents in the adenohypophysis and small intestine. The radioactive substance was accumulated more by the kidney than by the liver, but the hormone underwent inactivation more quickly in the liver.
INTRODUCTION
Vasopressin is an important hormone in mammals and has a considerable role in the regulation of a number of vital processes. To study its mechanism of action we felt it was necessary to know how it is cleared from the blood and we also wanted to collect data on its in-vivo metabolism. The low hormone level and its rapid degradation normally necessitate the use of a considerable multiple of the concentration of the physiological hormone. A concentration approaching that found under natural conditions has been attained with vasopressin labelled with a radioactive iodine isotope (Silver, Schwartz, Fong, Debons & Dahl, 1961; Klein & Roth, 1967; Baumann & Dingman, 1976; Shade & Share, 1976) , but the biological activity of the derivative was only a fraction of that of the unlabelled hormone. On the other hand, in experiments with tritium-labelled vasopressin, although the amount of hormone employed was similarly higher than the physiological level, this compound had full biological activity (Silver et al. 1961; Sjöholm & Rydén, 1967; Willumsen & Bie, 1969; László, 1979) .
Attempts to follow the processes of clearance and metabolism by bioassay are complicated (Schröder & Rott, 1959; Czaczkes & Kleeman, 1964; Fabian, Forsling, Jones & Pryor, 1969) and unreliable, while studies involving radioimmunoassay without a sufficiently specific antiserum have not given accurate results (Beardwell, 1971; Robertson, Mahr, Athar & Sinha, 1973; Skowsky, Rosenbloom & Fisher, 1974) .
Hormone passing out of the circulation is rapidly metabolized by various organs (e.g. liver and kidney). The undecomposed vasopressin has been determined by bioassay, by radioimmunoassay and by the measurement of radioactivity (Walter & Simmons, 1977) (Silver et al. 1961; Flouret, Terada, Yang, Nakagawa, Nakahara & Hechter, 1977) because of the methodological difficulties in its preparation and purification. In our earlier studies (László, 1979 3, Malmö, Sweden) by catalytic tritiation (Morgat, 1979 (Lindeberg, 1980 another metabolite, the in-vivo clearance of the labelled hormone was also determined using another method (Witter, Scholtens & Verhoef, 1980 (Silver et al. 1961 ; Klein & Roth, 1967; Baumann & Dingman, 1976; Shade & Share, 1976) , the labelling with iodine isotope meant a loss in biological activity (Fong, Silver, Christman & Schwartz, 1960) . Only LVP (László, 1979; Sjöholm & Yman, 1967; Willumsen & Bie, 1969) and synthetic dDAVP (László et al. 1981) have been labelled with tritium and examined. Although a hormone concentration higher than the natural one was used in these experiments, the biological activities were complete. Aziz (1969) to be 3-3-4-2 min and by Smith & Thorn (1965) to be 1-0 min, while by measurement of the pressor activity Gazis & Sawyer (1978) (Sjöholm & Rydén, 1967 (Fabian, Forsling, Jones & Lee, 1969) . Hormone metabolism may also be influenced by the blood circulation conditions. The vasopressin dose administered was larger than the pharmacological dose; it caused the blood pressure of the rats to increase by 25-50 mmHg, with a return to the initial value after 50-100 s. It is probable that the cardiovascular effect of the large dose of vasopressin changes the diffusion in the fast phase, but the half-life determined on the basis of the slow phase is characteristic of the substance. There is no correlation between the blood flow through the various organs and the distribution of radioactivity. For instance, the blood flow of the rat adenohypophysis is 0-76 + 0-06 (s.e.m.) pi/min per mg tissue, while that of the neurohypophysis is 5-05 + 0-73 pi/min per mg tissue (David, Csernay, László & Kovács, 1965) ; at the same time the radioactivity is accumulated to the greatest extent in the adenohypophysis. Larson (1938) demonstrated that an extract of small intestinal mucosa destroys the pressor activity of vasopressin.
The data from high-performance liquid chromatograms prepared after 2 and 5 min indicated that inactivation of the hormone was fastest in the small intestine, and the most radioactivity was accumulated here after 1 h. This observation appears to contradict the results of Lauson, Bocanegra & Beuzeville (1965) , who found that one-third of the circulating vasopressin is removed from the circulation by the liver and two-thirds of it by the kidney. Our data suggest that the metabolic activity is more marked in the kidney than in the liver and thus, in agreement with the observations of other authors, the majority of the hormone is removed from the circulation by the kidney (Little, Klevay, Radford & McGandy, 1966; Rabkin, Ghazeleh, Share, Crofton & Unterhalter, 1980) . The rate of inactivation, however, is more pronounced in the liver (Dicker & Greenbaum, 1956) ; this is supported by our radiochromatograms taken after 2 and 5 min: after 2 min the [3H]AVP accounts for 5-4% of the radioactivity in the kidney but only 2-7% in the liver. The phenomenon may be explained by the different enzymatic activities, or by the fact that there are specific vasopressin receptors in the kidney, whereas only non-specific membrane binding is to be found in the liver (Rabkin et al. 1980 (László, 1979) . Our present data are in accordance with the observations by Willumsen & Bie (1969) , who measured considerable radioactivity in both organs, 2 and 12 min after the intravenous administration of [3H]LVP. Plis"ka, Thorn & Vilhardt (1971) reported that the neurohypophysis also contains vasopressin-inactivating aminopeptidase and trypsin-like enzymes.
